Insider Trading & Ownership of Jane Wasman
-
Location
-
Ardsley, NY
-
Summary
-
The estimated net worth of Jane Wasman is at least $589,306 dollars as of 09 Jan 2026. Jane Wasman is the Director of SELLAS Life Sciences Group, Inc. and owns shares of SELLAS Life Sciences Group, Inc. (SLS) stock worth about $350.2K. Jane Wasman is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $238.2K. Jane Wasman is the Director of ATHERSYS, INC / NEW and owns shares of ATHERSYS, INC / NEW stock worth about $879.
-
Signature
-
/s/ Daniel Bagliebter, Power of Attorney for: Jane Wasman
Follow Filing Activity
Follow Jane Wasman and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Quick Takeaways
- Jane Wasman has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $589,306.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: SELLAS Life Sciences Group, Inc. ($350,177).
- Past-year value change for that position: +$33,800.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Jane Wasman
Insider Transactions Reported by Jane Wasman:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.